Back to News
Market Impact: 0.2
Leerink Partners Initiates Coverage of Harrow at Outperform
Source: Nasdaq
Analyst InsightsHealthcare & Biotech
Leerink Partners initiated coverage of Harrow (NASDAQGM:HROW) with an Outperform rating on September 9, 2026. Harrow shares closed at $37.85 on September 8 and had risen 2.38% over the referenced prior period, signaling modestly positive analyst sentiment.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
HROW0.45
More News
- How Pepsi fell behind in the cola wars—and then lost KFC
- 5 big analyst AI moves: ’Uniquely catalyst-rich’ months ahead for SpaceX
- Xencor reports phase 1 data for cancer drug XmAb819
- Biotech stocks are surging. How investors can play the new drug innovation boom
- UK immigration crackdown threatens £15 billion care sector
- Goldman says these top tech stocks have plenty of upside ahead of earnings
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: Advanced Search Filters, Redesigned Ticker Dashboard, and Improved Search Experience
- How to Build an Automated Research Process for a Fund